Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.

Author: BaconTeresa, BoonRon, EsserKlaus, LearyJeffry, LockeLeslie, NguyenTammy T, SaltzmanRobin, SariskyRobert T

Paper Details 
Original Abstract of the Article :
The antiherpesvirus agent penciclovir (PCV) shares an identical activation pathway and a similar mode of action with acyclovir (ACV). However, since PCV represents a relatively recent treatment option, the clinical resistance profile to PCV is less well known. A susceptibility program was establishe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1128/AAC.46.9.2848-2853.2002

データ提供:米国国立医学図書館(NLM)

Penciclovir: A Reliable Treatment for Herpes Labialis?

This study examines the effectiveness of penciclovir (PCV) in treating recurrent herpes labialis, a common infection that can be as uncomfortable as a persistent desert sandstorm. The study investigates the susceptibility of herpes simplex virus (HSV) isolates to PCV in patients using the cream to treat recurrent outbreaks.

Assessing Resistance to Penciclovir

The researchers established a susceptibility program to evaluate PCV resistance in patients with recurrent herpes labialis. It's like testing the strength of a desert fortress against a persistent enemy. The study found that PCV resistance was rare and that the virus quickly became susceptible to the treatment again.

Effective Treatment for Herpes Labialis

This study provides reassurance for individuals using PCV to treat recurrent herpes labialis. It's like discovering a reliable oasis in a vast desert, offering comfort and relief. The findings suggest that PCV is an effective treatment option, providing control over outbreaks and reducing the risk of resistance.

Dr. Camel's Conclusion

This study investigated the effectiveness of penciclovir in treating recurrent herpes labialis. It's like exploring a desert oasis, discovering that it can provide reliable relief from a persistent sandstorm. The study suggests that penciclovir is a safe and effective treatment option for recurrent herpes labialis, offering comfort and control to those affected.

Date :
  1. Date Completed 2003-02-13
  2. Date Revised 2021-05-26
Further Info :

Pubmed ID

12183237

DOI: Digital Object Identifier

10.1128/AAC.46.9.2848-2853.2002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.